Wong A O, Moor B C, Hawkins C E, Narayanan N, Kraicer J
Department of Physiology, University of Western Ontario, London, Canada.
Neuroendocrinology. 1995 May;61(5):590-600. doi: 10.1159/000126884.
The growth hormone (GH)-releasing action of GH-releasing factor (GRF) is known to be cAMP-dependent. However, definitive proof for the involvement of the cAMP-dependent enzyme protein kinase A (PKA) is still lacking. In this study, we characterized the PKA system in purified rat somatotrophs and examined its role in mediating GRF-stimulated GH release under static incubation conditions. PKA enzyme activity was detected only in the cytosolic, but not the particulate fraction of rat somatotrophs. This cytosolic PKA activity exhibited the characteristic cAMP dependence (with ED50 of 0.1 microM), ability to phosphorylate kemptide (a synthetic peptide with a PKA phosphorylation site), and susceptibility to inhibition by the bovine heat-stable PKA inhibitor. GRF treatment (1 pM-1 nM) stimulated the cytosolic PKA activity and GH release from rat somatotrophs in a dose-dependent manner. Time-course studies also demonstrated that activation of cAMP synthesis and PKA activity preceded the GH response to GRF. Stimulation of cytosolic PKA activity in rat somatotrophs by the adenylate cyclase activator forskolin (10 nM-1 microM) and membrane permeant cAMP analog db.cAMP (5 microM-0.5 mM) mimicked the GH-releasing effect of GRF. In contrast, Rp.cAMP, a cAMP antagonist for PKA regulatory subunits, blocked both the cytosolic PKA activity as well as GRF-induced GH release. Similar inhibitions were also observed when an inhibitor for PKA catalytic subunits, H89, was used. Somatostatin (SRIF) (1 nM), the physiological GH-release inhibitor, suppressed the GH response to GRF without affecting the basal or GRF-stimulated PKA activity. SRIF at a higher dose (10 nM) abolished the GH-releasing effect of GRF. In this case, SRIF also induced a small but significant inhibition of GRF-stimulated PKA activity. Taken together, the present study provides direct evidence that PKA enzyme activity is localized only in the cytosol of rat somatotrophs and constitutes an essential component of the signal transduction mechanism for GRF-stimulated GH release. This cytosolic PKA system, however, does not appear to be a major target for the GH-release inhibiting action of SRIF.
生长激素释放因子(GRF)的生长激素(GH)释放作用已知是依赖于环磷酸腺苷(cAMP)的。然而,仍缺乏关于依赖cAMP的酶蛋白激酶A(PKA)参与其中的确切证据。在本研究中,我们对纯化的大鼠生长激素细胞中的PKA系统进行了表征,并在静态孵育条件下研究了其在介导GRF刺激的GH释放中的作用。PKA酶活性仅在大鼠生长激素细胞的胞质部分检测到,而在微粒部分未检测到。这种胞质PKA活性表现出典型的cAMP依赖性(半数有效浓度(ED50)为0.1微摩尔),能够磷酸化肯普肽(一种具有PKA磷酸化位点的合成肽),并且对牛热稳定PKA抑制剂敏感。GRF处理(1皮摩尔至1纳摩尔)以剂量依赖性方式刺激大鼠生长激素细胞的胞质PKA活性和GH释放。时间进程研究还表明,cAMP合成和PKA活性的激活先于GH对GRF的反应。腺苷酸环化酶激活剂福斯可林(10纳摩尔至1微摩尔)和膜通透性cAMP类似物二丁酰环磷腺苷(db.cAMP)(5微摩尔至0.5毫摩尔)刺激大鼠生长激素细胞的胞质PKA活性,模拟了GRF的GH释放效应。相反,PKA调节亚基的cAMP拮抗剂Rp.cAMP阻断了胞质PKA活性以及GRF诱导的GH释放。当使用PKA催化亚基的抑制剂H89时,也观察到了类似的抑制作用。生长抑素(SRIF)(1纳摩尔),生理性GH释放抑制剂,抑制了GH对GRF的反应,而不影响基础或GRF刺激的PKA活性。较高剂量(10纳摩尔)的SRIF消除了GRF的GH释放效应。在这种情况下,SRIF也对GRF刺激的PKA活性产生了轻微但显著的抑制作用。综上所述,本研究提供了直接证据,表明PKA酶活性仅定位于大鼠生长激素细胞的胞质中,并且是GRF刺激的GH释放信号转导机制的重要组成部分。然而,这种胞质PKA系统似乎不是SRIF抑制GH释放作用的主要靶点。